Logo image
Targeting the sumoylation pathway in cancer stem cells
Journal article   Open access

Targeting the sumoylation pathway in cancer stem cells

Maria V Bogachek, James P De Andrade and Ronald J Weigel
Molecular & cellular oncology, Vol.1(3), pp.e964624-e964624
09/15/2014
DOI: 10.4161/23723548.2014.964624
PMCID: PMC4905063
PMID: 27308355
url
https://doi.org/10.4161/23723548.2014.964624View
Published (Version of record) Open Access

Abstract

Cancer stem cells (CSCs) represent a subset of tumor cells with tumor-initiating potential. We recently demonstrated that inhibition of the sumoylation pathway cleared the CSC population and repressed the outgrowth of basal breast cancer xenografts. Targeting the sumoylation pathway offers a novel treatment strategy for basal breast cancer.
basal breast cancer cancer stem cells CD44 epithelial-mesenchymal transition SUMO sumoylation TFAP2A

Details

Metrics

Logo image